This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page

Menu

Close

AboutAboutEnbrel commitment to inflammation careDosingDosingEnbrel dosing and administrationMyClic pre-filled penPre-filled syringeMyClic administrationPowder and solventEfficacy and SafetyEfficacy and SafetyEnbrel therapeutic indicationsRheumatoid arthritisJuvenile idiopathic arthritisPsoriatic arthritis
Ankylosing spondylitisPlaque psoriasis
Support & ResourcesSupport & ResourcesEnbrel patient supportOrder patient materialsEnbrel: Sleeve for MyClic pre-filled pensVideosMaterials

Information on how to access Enbrel® (etanercept) and Maxtrex (methotrexate) prescribing information and adverse event reporting can be found at the bottom of the page.

Enbrel® Together Programme Patient Support

All Enbrel patients have access to initial home visits for injection training following approval from their hospital:

New starter home visits: one initial training visit with more available by request to help with injection training, support to help patients understand their condition, treatment, dose and importance of adherence

All Enbrel patients also have access to the Together programme website. Content is released over the course of a year, specifically tailored to their condition, administration method and length of time on treatment.

Enbrel Homecare Medicines delivery service

In addition to the Together Enbrel Patient Support Programme, Pfizer provides a flexible Homecare Medicines Delivery Service that ensures Enbrel patients have an on-going and consistent supply of their medicine:

  • Repeat prescription management: ensuring that patients have a valid prescription at all times
  • Patient stock management: check and record patients stock levels, with evidence of over or under use of medicines reported to the healthcare organisation
  • Dispensing/checking
  • Delivery: directly to a patient’s home, place of work, named friend or relative’s home
  • Clinical waste collection and disposal
Patient support website 

Please find below a 1 minute 54 second video introducing Enbrel’s new patient support website.

Pfizer Together programme

Explore more​​​​​​ Order patient materials

A range of patient materials are available for your Enbrel patients

Find out more Loading
Enbrel: Sleeve for MyClic pre-filled pens

The MyClic Sleeve has been designed for patients with poor dexterity

Explore more​​​​​​ Loading

Prescribing information

Enbrel (etanercept) prescribing information,  Enbrel PI
Maxtrex (methotrexate) prescribing information, Maxtrex PI 

 

 To retun to the homepage click Enbrel (etanercept)

PP-ENB-GBR-1122. January 2023
Pfizer Enbrel is commited to inflammation care in the UK. Find out more Loading

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2023 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7284. November 2023
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​